Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03803345
Other study ID # CIRB 2018/2529
Secondary ID
Status Completed
Phase
First received
Last updated
Start date March 28, 2019
Est. completion date March 11, 2022

Study information

Verified date August 2022
Source KK Women's and Children's Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study aims to assess the associations of maternal food timing with glucose levels during pregnancy.


Description:

A novel line of research has emerged, suggesting that synchronizing the timing of food intake with body's circadian rhythms or day-night cycle has metabolic implications. Eating at the inappropriate time can disrupt circadian system which might induce metabolic perturbations, including glucose abnormalities. Recent evidence showed that circadian timing of eating was associated with glucose regulation in pregnant women. However, little is known about night-eating pattern during pregnancy, particularly the influence of nocturnal snacking on glycaemic control. This cross-sectional study aims to recruit 400 pregnant women at 18-21 weeks' gestation. The investigators will assess maternal dietary intake, monitor 24-hour activity-rest pattern and light-dark exposure, and measure glucose and insulin profiles during the second trimester of pregnancy. Maternal socio-demographic status, lifestyle characteristics, health conditions and pregnancy outcomes will be asked through interview or retrieved from medical notes. This study allows understanding the importance of circadian eating pattern, which is a modifiable behavior, in glycaemic control during pregnancy, and help to provide evidence for developing nutritional guidelines which can ameliorate metabolic health for mothers.


Recruitment information / eligibility

Status Completed
Enrollment 300
Est. completion date March 11, 2022
Est. primary completion date December 24, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: 1. 18-21 week's gestation 2. Singapore citizens or Singapore Permanent Residents 3. Age 18-45 years 4. Plan to follow-up for antenatal care in KK Women's and Children's Hospital 5. Intend to deliver in KK Women's and Children's Hospital 6. Provide written informed consent Exclusion Criteria: 1. Type 1 or 2 diabetes 2. Diabetes in pregnancy as confirmed by oral glucose tolerance test 3. Use of medications such as anticonvulsant medications or oral steroids in the past 1 month 4. Multiple pregnancy 5. On routine night-shift work for at least 3x/week over the past 1 month 6. Known or suspected allergy to medical grade adhesives 7. Chronic kidney diseases 8. Preeclampsia 9. Eventual miscarriage or undergo termination event

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Singapore KK Women's and Children's Hospital Singapore

Sponsors (4)

Lead Sponsor Collaborator
KK Women's and Children's Hospital Duke-NUS Medical School (Singapore), National University Hospital, Singapore, National University, Singapore

Country where clinical trial is conducted

Singapore, 

Outcome

Type Measure Description Time frame Safety issue
Other Maternal hypertension status Maternal hypertension status obtained from medical notes. Up to 42 weeks, during pregnancy
Other Maternal delivery outcomes Maternal delivery outcomes obtained from medical notes. Up to 72 hours, after delivery
Other Birth weight Offspring birth weight in gram obtained from medical notes. Up to 72 hours, after delivery
Other Birth length Offspring birth length in cm obtained from medical notes. Up to 72 hours, after delivery
Other Birth head circumference Offspring birth head circumference in cm obtained from medical notes. Up to 72 hours, after delivery
Primary Maternal glucose tolerance Maternal glucose tolerance based on plasma glucose levels as assessed by the Oral Glucose Tolerance Test. Up to 4 weeks, during second trimester of pregnancy
Primary Maternal night-eating pattern Maternal night-eating pattern as assessed by the food diary and food record app. Up to 4 days, during second trimester of pregnancy
Primary Maternal meal and snack distribution Maternal meal and snack distribution as assessed by the food diary and food record app. Up to 4 days, during second trimester of pregnancy
Secondary Maternal insulin profile Maternal insulin profile as assessed by the fasting insulin level. Up to 4 weeks, during second trimester of pregnancy
Secondary Maternal gestational diabetes status Maternal gestational diabetes status as assessed by the Oral Glucose Tolerance Test. up to 4 weeks, during second trimester of pregnancy
Secondary Maternal glycemic variability Maternal glycemic variability based on continuous glucose monitoring profile as assessed by the continuous glucose monitoring system (Freestyle Libre Pro, Abbott). Up to 10 days, during second trimester of pregnancy
Secondary Maternal diet quality Maternal diet quality as assessed by the Food Frequency Questionnaire. up to 1 month, during second trimester of pregnancy
Secondary Maternal type of food intake Maternal type of food intake as assessed by the food diary, food record app and Food Frequency Questionnaire. up to 10 weeks, during second trimester of pregnancy
Secondary Maternal nutritional intake Maternal nutritional intake as assessed by the food diary and food record app. Up to 4 days, during second trimester of pregnancy
Secondary Maternal eating frequency Maternal eating frequency as assessed by the food diary and food record app. Up to 4 days, during second trimester of pregnancy
Secondary Maternal meal and snack regularity Maternal meal and snack regularity as assessed by the questionnaire based on frequency of meal/ snack delay and skipping. Up to 1 month, during second trimester of pregnancy
Secondary Maternal physical activity Maternal physical activity as measured by the Actigraph accelerometer. Up to 10 days, during second trimester of pregnancy
Secondary Maternal physical activity Maternal physical activity as assessed using the modified International Physical Activity Questionnaire (IPAQ). Up to 1 week, during second trimester of pregnancy
Secondary Maternal sedentary behavior Maternal sedentary behavior as measured by the Actigraph accelerometer. Up to 10 days, during second trimester of pregnancy
Secondary Maternal sedentary behavior Maternal sedentary behavior as assessed using the structured questionnaires based on frequency and duration of time spent in sedentary behaviour. Up to 1 week, during second trimester of pregnancy
Secondary Maternal sleep related behavior Maternal sleep related behaviour as measured by the Actigraph accelerometer. Up to 10 days, during second trimester of pregnancy
Secondary Maternal sleep related behavior Maternal sleep related behavior as assessed using the Pittsburgh Sleep Quality Index (PSQI) questionnaire. Up to 1 month, during second trimester of pregnancy
Secondary Maternal light exposure Maternal light exposure as measured by the Actigraph accelerometer. Up to 10 days, during second trimester of pregnancy
Secondary Maternal light exposure Maternal light exposure as assessed by the Harvard Light Exposure Assessment (H-LEA) questionnaire. Up to 1 week, during second trimester of pregnancy
Secondary Maternal electronic media use before bedtime Maternal electronic media use before bedtime as assessed by the structured questionnaire based on frequency, duration and location of electronic device use. up to 1 week, during second trimester of pregnancy
Secondary Maternal mood Maternal mood as assessed by the Depression Anxiety Stress Scale (DASS21) questionnaire. Up to 1 week, during second trimester of pregnancy
Secondary Maternal gestational weight gain Maternal weight measured by calibrated weighing scale as recorded in medical notes Up to 42 weeks, throughout pregnancy
Secondary Dietary data from food record app. Feasibility and validity of using food record mobile app to capture maternal dietary intake, compared with paper-based food diary. up to 4 days, during second trimester of pregnancy
See also
  Status Clinical Trial Phase
Completed NCT06188728 - Husk Fiber Intervention on Metabolic Health of Centrally Obese School Teachers N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05081037 - Integrated Hyperglycaemia Incentivised Postnatal Surveillance Study (I-HIPS) N/A
Recruiting NCT05318196 - Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
Not yet recruiting NCT05461144 - AI Models for Non-invasive Glycaemic Event Detection Using ECG in Type 1 Diabetics
Recruiting NCT05544266 - Rare and Atypical Diabetes Network
Recruiting NCT04039763 - RT-CGM in Young Adults at Risk of DKA N/A
Active, not recruiting NCT05505994 - The Efficacy and Safety of DWP16001 in Combination With Metformin in T2DM Patients Inadequately Controlled on Metformin Phase 3
Completed NCT03859934 - Metabolic Effects of Melatonin Treatment Phase 1
Completed NCT03675360 - Low-Carbohydrate Dietary Pattern on Glycemic Outcomes Trial N/A
Recruiting NCT05711758 - Efficacy and Safety of Endoscopic Antral Myotomy as a Novel Weight Loss Procedure
Recruiting NCT05112029 - Metabolic Profile and Adipokine Levels in Young Hyperandrogenemic Females
Recruiting NCT03682640 - Azithromycin Insulin Diet Intervention Trial in Type 1 Diabetes Phase 2
Completed NCT04854603 - Dairy Products With Reduced Sugar and Blood Glucose N/A
Recruiting NCT06024291 - Reducing Circulating Sphingolipid Levels to Optimise Cardiometabolic Health - The SphingoFIT Trial N/A
Recruiting NCT04904601 - Freeze-dried Kale to Reduce Metabolic Risk in Saudi Subjects N/A
Recruiting NCT04109586 - Diet and Fat Mass After Traumatic Spinal Cord Injury N/A
Recruiting NCT06009653 - Effect of Tirzepatide Plus Intensive Lifestyle Therapy on Body Weight and Metabolic Health in Latinos With Obesity Phase 4
Completed NCT03067012 - Nutritional Safety and Metabolic Benefits of Oncometabolic Surgery for Obese Gastric Cancer Patients N/A
Recruiting NCT03309423 - Is Venous to Arterial Conversion (v-TAC) of Blood Gas Reliable in Critical Ill Patients in the ICU? N/A